for call guidance we year. balance quarter XXXX that, morning, the will call, operating business On review we questions. third today's thank After open will of joining results a for our update, of for the us. provide Good provide for our and the and you the
our accelerate begin with preserve deliver adoption, map to commercial our to priorities our will XXXX: and innovation corporate strength. to an financial road on I for X on update
Our commercial first adoption. accelerate corporate to priority is
of rapidly proteomics ramp-up made that are continued Platinum. an the XXXX, well we commercial progress be the positioned in growing the quarter we market. of in to We third During believe company industry-leading
technology, intellectual drive and create coming has robust confidence from growth market portfolio. can years. that over the best-in-class believe our Our our comes the We first-mover technology opportunities potential our to large, that advantage new property
commentary Consistent peers, the third sales lengthening the from many with observed quarter. some our in we of cycle of the
Our third was our quarter revenue XXXX of $XXX,XXX expectations. below
to not did customers any we originally that their we out communicated. than date lose see push While instrument opted did a deals, purchase of to later an
be our small early this commercialization, can expectations stage between difference deals delayed not. of At or meeting being the a number of
quarter, As to headwinds we fourth look the and tailwinds there consider. are both to
for to to territories days pleased I of we new there XX am our our is last a industry most That in become of sales have open around I the fully effective. call. filled said, period on mentioned that ramp-up salesperson report any
we So our the next to of early expect sales benefit year. impact positively results full these professionals new by
his background and Abbott, Further, with and leadership we in at an of life Chief includes Officer. appointed record brings Todd Immucor. commercial XX outstanding track experience Commercial sciences and Luminex, in years as our more Roche Bennett Todd than September, diagnostics roles
Todd steps to process, reach. partners extend training our taken channel our our programs enable and streamline has sales already bolster new commercial to
leadership. of a On our rapid execution our we acceleration an positive and force side, overall pipeline observing sales the are improvement in Todd's sales under
industry the fourth to our an look as spending year-end. capital customers budget any remaining uptick in in sees quarter Additionally, often deploy by
to are not well it may uptick any positioned be, purchasing how instrument our While point. we yet this is given end-of-year from benefit capital clear price significant
quarterly are to guidance. in confident achieve sequential will revenue said, QX expect revenue million XXXX first full we our for that That revenue On the is of increase in in generate likely and balance, not it we we that time. will year surpass a $X
laser-focused as get guidance to full as execution are to year close commercial strategies We our try clear possible. to with place in on
execution, capabilities These customer commercial help as points our we of help generate their push efforts scientific are in our integrate research will affairs at Platinum the programs market. customers continued publications our to released result technology data unique adoption through and as group important the Beyond into adding scientific broader industry new peer-reviewed of the proof that of have conferences and affairs in Platinum. to that initiatives being increase publications accelerate resources to including well awareness
how poster Last meeting variants modifications month, Human protein such can productive Proteome World well Germany. to detecting as address had highlight Platinum protein at the applications post-translational as we barcoding. presentations included a Organization as in This very Congress and
presented We which University on top-down our researchers analysis. spectrometry integrating in also session to with platform hosted enhance Northwestern Platinum proteoform from mass a
we progress commercial making on Overall, are front. the great
ability Given commercial are these ever optimism Todd's of as to technology of of segments adoption impact full still being changes front market across the recent, the execution it made our us. My under improvements expand leadership is high all has as relatively our been. in about is
opportunities taken Since puts Quantum-Si. Our more our new become cycle programs road chemistry We long-term in a exciting the clear scale the consumables, our position the capabilities to exciting software reads. initiatives overall expand on to proteomics. realigning output you'll but plan billions our sample and believe opportunity per innovation. we of path I preempt of second and don't our to about map. to technology clear is last future started to of and advancements runner will demonstrate fall, new to really R&D priority on open these groundbreaking advances us we hardware, front We an we Investor on week, have our believe innovation to next want us large, that shape market have in will deliver Day learn to have jump
In showcase that delivery of we market. accelerate will new partnerships this addition, the cycle innovation help also of the will important to
with our kit Next, new barcoding are I kit reduce quarter. the prep our preparation are expand success of to our compatible am starting sample library range sample expected increase the pleased during system kit next is The launch and overall for and library the to on input proteins amount, version rate. report track the fourth that that of
provide The is dynamic while expected prior range barcoding to the significant sensitivity prep customers application. sample time a improving of also and sequencing, to reduction kit in the
Our our contribution panel continued also We gone and technology to unnoticed. our of innovation QSI on field the ongoing not innovation Innovation has with pioneering of by were experts our property to advancing success. They intellectual honored Award. Sullivan Technology robust proteomic independent the research. foundational and recognized recently that long-term is based commitment selected portfolio to prestigious their & An Frost Leadership of
American they where Conference the of Platinum Felton's biology. California, the showcased of full with attended using with Protein week, Sequencing the Society genomic Researchers and transcriptomic demonstrated of complexity how better capture last Santa Cruz. collaboration Additionally, to Genetics augment lab Next-Generation are Dr. Human we data from we University the and
pipeline on be innovation for is Day our track able exciting. is deeper details the road our to our complete have Overall, on map Once Investor XX, we conversations up the we shaping and very it and future. of will on November how
financial preserve strength. priority is to Our our third
with capital. will committed progress balances road on provide map We remain innovation pleased the our remain maximum discipline sufficient Jeff preserving and we our of are that capital. financial more with financial we of continue details, our to but laser-focused output to use
our results. financial call turn now to the review Keyes Jeff to will over I